PsiThera Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$25M
- Investors
-
8
PsiThera General Information
Description
Developer of a physics-driven drug discovery platform designed to facilitate small-molecule engineering. The company's platform utilizes proprietary computational physics modeling, molecular dynamics, and artificial intelligence to provide cryptic pocket identification, protein motion simulation, and small-molecule design, enabling biopharmaceutical companies to increase therapeutic accessibility and manage oral drug development for immunology targets through a unified digital environment.
Contact Information
Website
www.psithera.comCorporate Office
- 66 Galen Street
- Suite 202
- Watertown, MA 02472
- United States
Corporate Office
- 66 Galen Street
- Suite 202
- Watertown, MA 02472
- United States
PsiThera Timeline
PsiThera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 10-Nov-2026 | $25M | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 10-Dec-2025 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 08-Mar-2024 | $50M | $50M | Completed | Startup |
PsiThera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Roivant |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
PsiThera Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PsiThera Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PsiThera Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| Lumination Capital | Venture Capital | Minority | ||
| Roivant Sciences | Corporation | Minority | ||
| Samsara BioCapital | Venture Capital | Minority | ||
| YK Bioventures | Venture Capital | Minority |
PsiThera Investments (1)
PsiThera’s most recent deal was a Early Stage VC with Freecurve Labs. The deal was made on 01-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Freecurve Labs | 01-Oct-2024 | Early Stage VC | Other Commercial Services |
PsiThera FAQs
-
When was PsiThera founded?
PsiThera was founded in 2022.
-
Where is PsiThera headquartered?
PsiThera is headquartered in Watertown, MA.
-
What is the size of PsiThera?
PsiThera has 34 total employees.
-
What industry is PsiThera in?
PsiThera’s primary industry is Drug Discovery.
-
Is PsiThera a private or public company?
PsiThera is a Private company.
-
What is PsiThera’s current revenue?
The current revenue for PsiThera is .
-
How much funding has PsiThera raised over time?
PsiThera has raised $122M.
-
Who are PsiThera’s investors?
AbbVie Ventures, Lumination Capital, Roivant Sciences, Samsara BioCapital, and YK Bioventures are 5 of 8 investors who have invested in PsiThera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
